<unk>  refers to a salvage regimen consisting of rituximab, etoposide, (Solumedrol, high-dose), cytarabine (Ara-C), and cisplatin (Platinol) used to treat refractory diffuse large B-cell lymphoma.
R-ESHAP regimen
Mito-FLAG regimen
FLAG regimen
ACVBP-R regimen
FLAMSA-BU regimen
CAPOX regimen
R-GCVP regimen
R-CVP regimen